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ommon and Missing Links
e read with great interest the study by Shiroto et al. (1), who
dentify the Rho-kinase (ROCK) pathway to play a role in the
athogenesis of drug-eluting stent (DES)-induced coronary hy-
erconstrictive responses. Specifically, they observed paclitaxel-
nduced up-regulation of ROCK in cultured human coronary
ascular smooth muscle cells and found increased serotonin-
ediated vasoconstriction at the stent edges of paclitaxel-eluting
tents (PES) and sirolimus-eluting stents (SES) as compared with
are-metal stents (BMS) in a porcine coronary stent model.
ntracoronary administration of the ROCK inhibitor hydroxyfa-
udil diminished hyperconstriction for PES and SES, and
radykinin-mediated vasodilation with and without nitric oxide
ynthase inhibitor administration was not altered for PES. As
xpected, decreased neointimal formation and re-endothelialization
nd increased microthrombus formation and inflammation were
ound in DES compared with BMS. These exciting data add
mportant aspects to the current understanding of DES-induced
ascular dysfunction.
In this context, we would like to point out that vascular
ysfunction is also associated with increased vascular oxidative
tress induced by sirolimus and mediated by superoxide from
itochondrial and nicotinamide adenine dinucleotide phosphate
NADPH) oxidase sources (2). Given the different subcellular
arget structures as well as pharmacological properties, one should
e cautious to extrapolate the observed paclitaxel-mediated effects
n ROCK to sirolimus and other anti-restenotic drugs. In partic-
lar, the ROCK inhibitor hydroxyfasudil used by Shiroto et al. (1)
as also been shown to suppress increased vascular NADPH
xidase expression and endothelial superoxide anion production,
hereby ameliorating the impaired endothelium-dependent relax-
tion caused by angiotensin II infusion, in a previous thorough
tudy by the authors (3). As pointed out in the interesting Editorial
omment (4), the observed increase in ROCK expression and
ctivity at the stent site could be stimulated at least in part by local
nflammatory responses, a condition involving increased vascular
xidative stress as well. When interpreting the PES data, it should
e kept in mind that paclitaxel can also promote the generation of
eactive oxygen species through enhancing NADPH oxidase
ctivity, causing damage even to adjacent cells not directly exposed
o the drug (5). In addition, paclitaxel was found to stimulate
itochondrial reactive oxygen species formation by cytochrome
xidase and mediate their release through the permeability transi-
ion pore in isolated mitochondria (6).
Conclusively, future studies investigating the pathomecha-
isms leading to clinical complications of DES implantation
ill have to further elucidate the specific cell types and pathways
nvolved. Herein, inflammatory responses may play a central
ole, linking drug and polymer effects with oxidative stress and
he resulting activation of subcellular pathways leading to
oronary endothelial and vascular dysfunction, impairment of
oronary collateral function, delayed re-endothelialization, and
ate stent thrombosis. cAlexander Jabs, MD
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eply
e appreciate the valuable comments of Drs. Jabs and Münzel on
ur paper (1). Indeed, they addressed an important issue, the role
f vascular reactive oxygen species in drug-eluting stent (DES)–
nduced vascular dysfunction. In their study using rats, a contin-
ous (7-day) systemic sirolimus treatment impaired endothelium-
ependent and -independent vascular relaxation, and up-regulated
itochondrial superoxide release and the nicotinamide adenine
inucleotide phosphate-mediated vascular superoxide production
2). Production of superoxide in the vessel wall has been shown to
nactivate nitric oxide, leading to impaired endothelium-
ependent vasodilation (3).
In our porcine model (1), since endothelial vasodilator function
as preserved at the stent edges of DES with hyperconstrictive
esponses, we consider that endothelial dysfunction that could
nhance reactive oxygen species generation may not be involved in
he enhanced vascular responses. However, as Drs. Jabs and
ünzel suggested, DES-induced inflammatory responses could
voke vascular reactive oxygen species. The recent pathological
tudy (4) demonstrated intense and extensive inflammatory re-
ponse at the DES site, a consistent finding with our present study
5). Potential association between inflammation and oxidative
tress (measured by luchigenin luminometry) has also been re-
orted in a porcine model with paclitaxel-eluting stents (5).
The Rho-kinase pathway up-regulates molecules relating to
nflammation and oxidative stress (6). In our present study (1),
ES caused coronary vasoconstricting responses to serotonin as
ompared with BMS in vivo, which were abolished by hydroxy-
f
r
a
o
s
i
t
d
*
T
H
*
T
1
A
S
J
E
R
1
2
3
4
5
6
7
1400 Correspondence JACC Vol. 55, No. 13, 2010
March 30, 2010:1396–400asudil, a selective Rho-kinase inhibitor. Interestingly, it was
eported that Rho-kinase inhibitor Y-27632 inhibited the
ntiangiogenic effect of isoprostane 8-iso-PGF2, a marker of
xidative stress, on endothelial cells (7). Although further
tudies are needed, our present study indicates that Rho-kinase
s an important therapeutic target as it appears to be involved in
he pathogenesis of DES-induced vascular inflammation and
ysfunction.
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